Diagnosis of Wound Infections: Current Culturing Practices of U.S. Wound Care Professionals

Author(s): 
Richard Bamberg, PhD, SH(ASCP), MT(ASCP), CLD(NCA), CHES;1 P. Karen Sullivan, PhD, SM(ASCP), MT(ASCP);2 Teresa Conner-Kerr, PhD, PT, CWS(D)3

Introduction In recent years, substantive basic science and clinical research have been conducted to evaluate the mechanisms of wound healing, the efficacy of various modalities for treatment of wounds, and the best methods for diagnosing wound infection. A great deal of this effort has been directed toward evaluating the most accurate and reproducible methods for diagnosing chronic wound infection. From the surface, this seems like a fairly simple clinical question. However, it quickly becomes apparent that this question is quite involved. For example, chronic wounds often harbor bacteria at levels many times that which constitute infection in an acute surgical wound (i.e., >= 105 microorganisms/gm of tissue); yet, many of these chronic wounds go on to closure despite levels of microorganisms as great as 108/gm of tissue.1–3 Chronic wounds are thought to be able to tolerate these high numbers of microorganisms because of the type and content of the microorganisms present in the wound bed. Chronic wounds often contain three or more microorganisms. These organisms include both gram-positive and -negative bacteria as well as both aerobic and anaerobic bacterial species. In fact, the cohabitation of these organisms and the resultant competition for nutrients and space is thought to decrease their virulence. As a result, higher numbers of microorganisms can be tolerated because of their decreased ability to harm tissue.1,4 Because of these intrinsic differences in the way acute and chronic wounds respond to varying levels of microorganism numbers,4 a greater emphasis is currently being placed on holistic assessment with clinical signs and symptoms playing key roles in diagnosis of chronic wound infection. The classical signs of infection (erythema, edema, heat, purulent exudate, and pain) have been modified to include serous exudate with concurrent inflammation, delayed healing, discoloration of granulation tissue, friable granulation tissue, pocketing at the base of the wound, foul odor, and wound breakdown as these signs appear to be more predictive of chronic wound infection. Increasing pain and wound breakdown have been shown to be particularly good predictors of infection in the chronic wound.5 However, there are several intrinsic limitations to diagnosing a wound infection and establishing a treatment paradigm via clinical signs and symptoms alone. Of particular concern is the constantly evolving number of microorganisms with antibiotic resistance. While the evaluation of clinical signs and symptoms may prove to be a very cost-effective and expedient method for diagnosing chronic wound infection, the use of this method alone does not inform the wound care clinician of the most appropriate chemotherapeutic approach to treatment. Use of clinical signs and symptoms alone leaves the provider to select a therapeutic agent based on little specific information about the particular pathogen(s). As a result, broad-spectrum chemotherapeutic agents may be initiated that only serve to facilitate the development of antibiotic resistance. The use of clinical signs and symptoms to predict the need for wound culturing has been suggested in the literature.5,6 However, this points to another controversy in the practice of diagnosing wound infection—which methods are best? The method used for collection of wound specimens can influence the data obtained from microbiological culturing. Currently, collection of a biopsy specimen is the gold standard for determining the presence and identity of microorganisms within the wound bed tissue. However, there are limitations as to which healthcare providers can collect biopsies, availability of laboratories offering microbiological culture testing on biopsies, the expenses involved with performance of these tests, and the potential for further tissue damage and delay of healing when biopsies are taken.

References: 

References1.Bendy RH, Nuccio PA, Wolfe E, et al. Relationship of quantitative wound bacterial counts to healing decubiti: Effects of gentamicin. Antimicrob Agents Chemother 1964;4:147–55.2. Lookingbill DP, Miller SH, Knowles RC. Bacteriology of leg ulcers. Arch Derm 1978;114:1765–8.3. Teplitz C, Davis D, Mason AD, Moncrief JA. Pseudomonas burn wound sepsis. I: Pathogenesis of experimental burn wound sepsis. J Surg Res 1964;4:200–16.4. Dow G, Browne A, Sibbald RG. Infection in chronic wounds: Controversies in diagnosis and treatment. Ost/Wound Manag 1999;45:23–40.5. Gardner SE, Frantz RA, Troia C, et al. A tool to assess clinical signs and symptoms of localized infection in chronic wounds: Development and reliability. Ost/Wound Manag 2001;47:40–7.6. Krasner DL, Rodeheaver GT, Sibbald RG (eds). Chronic Wound Care: A Clinical Source Book for Healthcare Professionals, Third Edition. Wayne, PA: HMP Communications, 2001.7. Georgiade NG, Lucas MC, O’Fallon WM, et al. A comparison of methods for the quantitation of bacteria in burn wounds. Am J Clin Path 1970;53:35–9.8. Levine NS, Lindberg RB, Mason AD, et al. The quantitative swab culture and smear: A quick, simple method for determining the number of viable aerobic bacteria in open wounds. J Trauma 1976;16:89–94.9. Sapico FL, Witte JL, Canawati HN, et al. The infected foot of the diabetic patient: Quantitative microbiology and analysis of clinical features. Rev Infect Dis 1984;6(Suppl):171–6.10. Sapico FL, Ginunas VJ, Thornhill-Joynes M, et al. Quantitative microbiology of pressure sores in different stages of healing. Diag Microbiol Infect Dis 1986;5:31–8.11. Perry CR, Pearson RL, Miller GA. Accuracy of cultures of material from swabbing of the superficial aspect of the wound and needle biopsy in the preoperative assessment of osteomyelitis. J Bone Joint Surg 1991;73A:745–9.12. Rudensky B, Lipschits M, Issacsohn M, et al. Infected pressure sores: Comparison of methods for bacterial identification. South Med J 1992;85:901–3.13. Steer JA, Papini RPG, Wilson APR, et al. Quantitative microbiology in the management of burn patients I: Correlation between quantitative and qualitative burn wound biopsy culture and surface alginate swab culture. Burns 1996;22:175–8.14. Neil JA, Munroe CL. A comparison of two culturing methods for chronic wounds. Ost/Wound Manag 1997;43:20–30.15. Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 2001;14:244–69.16. Stotts NA. Determination of bacterial burden in wounds. Adv Wound Care 1995;8(Suppl):46–52.17. National Center for Health Statistics. National hospital discharge survey (vital health statistics, series 13, no. 19, appendix p. 114). Available at: http://www.cdc.gov/nchs. Accessed January 3, 2001.18. van Rijswijk L. Wound assessment and documentation. In: Krasner DL, Rodeheaver GT, Sibbald RG (eds). Chronic Wound Care: A Clinical Source Book for Healthcare Professionals, Third Edition. Wayne, PA: HMP Communications, 2001:112.19. Communicable Disease Centers. Overcoming Antimicrobial Resistance: World Health Organization Report on Infectious Diseases 2000. Geneva, Switzerland: Geneva World Health Organization, 2000. (http://www.who.int/ infectious-disease-report/2000).20. Neu HC. The crisis in antibiotic resistance. Science 1992;257:1064–73.21. Mainous AG, Pomeroy C (eds). Management of Antimicrobials in Infectious Diseases. Totowa, NJ: Humana Press, 2001.22. Meier KM, Dockter M. A survey of current physical therapy practices in wound care. Ost/Wound Manag 2002;48:36–42.